High expression of PI4K2A predicted poor prognosis of colon adenocarcinoma (COAD) and correlated with immunity.

Xinkun HuangYang CaoPeng BaoBingye ZhuZhouyang Cheng

Published in: Cancer medicine (2022)

Our study suggests that PI4K2A may be a potential predictor of poor prognosis in COAD and a potential biomarker for early diagnosis, prognosis, and treatment.

Keyphrases

poor prognosis
long non coding rna
combination therapy
risk assessment
rectal cancer